CClinicalTrials.gg
Status unknownNCT03386175TPNUpdated Sep 1, 2020

Efficiency of Negative Pression Therapy With Instillation in the Debridement of Wound

An observational study in Wound, sponsored by University Hospital, Grenoble. Status unknown at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2020-09-01.

Sponsored by University Hospital, Grenoble · Observational

The sponsor has not verified this record recently (last verified Aug 2020), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
20
Ages
18 Years and older
Sex
All
01

Study summary

the aim of the study is to evaluate the efficiency of the therapy with negative pression (TPN) and instillation in the debridement of chronic wound

Read the detailed description

it is an observation study with only the aim to evaluate the percentage of fibrin before and after the specific treatment of TPN

02

Conditions studied

  • Wound

Browse trials for

03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

patients with wound and fibrin more than 70%

Inclusion criteria

  • wound with debridement

Exclusion criteria

Exclusion Criteria:

-

04

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
20 participants (estimated)
Patient registry
No

Interventions

  • Devicetherapy with negative pression and instillation

    therapy with negative pression and instillation

05

What researchers measure

Primary outcomes

  1. percentage of fibrine

    percentage of fibrine

    Time frame: 1 day

06

Study locations

1 of 1 sites recruiting
  • Grenoble University hospital
    Grenoble, 38700, France
    Recruiting
07

Registry details

Key details

Study ID
NCT03386175
Lead sponsor
University Hospital, Grenoble
Responsible party
Sponsor
First posted
Dec 29, 2017
Start date
Oct 4, 2017
Primary completion
Dec 3, 2020 (estimated)
Completion
Dec 3, 2020 (estimated)
Last update
Sep 1, 2020

Study contacts

sophie blaise, MD PhD
Contact
SBlaise@chu-grenoble.fr
0033476765547

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Aug 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion